1 / 3

DNA Vaccines Elicit Antibodies Targeting the MPER of HIV-1 gp41

DNA Vaccines Elicit Antibodies Targeting the MPER of HIV-1 gp41. Jamie K . Scott, Simon Fraser University, Canada Funding: NIAID/NIH and CIHR The MPER of HIV gp41 is discreet 22-AA long region preceding the transmembrane region ( TM ) of Env .

stacie
Download Presentation

DNA Vaccines Elicit Antibodies Targeting the MPER of HIV-1 gp41

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DNA Vaccines Elicit Antibodies Targeting the MPER of HIV-1 gp41 Jamie K. Scott, Simon Fraser University, Canada Funding: NIAID/NIH and CIHR The MPER of HIV gp41 is discreet 22-AA long region preceding the transmembrane region (TM) of Env. It is the target of 3 broadly neutralizing antibodies (Abs), and 3 heterologous cross-neutralizing Abs against HIV. Hypothesis: The MPER’s neutralizing structure depends upon the viral membrane and constraint by the gp41 TM. Goal: Produce a DNA-prime, protein-boost vaccines that elicit broadly neutralizing Abs against the MPER, by associating it with lipid bilayer and tethering it with a TM.

  2. DNA Vaccines: The Nature of the TM Affects MPER-binding by Broadly Neutralizing Abs, 2F5 and 4E10 2F5 binds the C-terminus of the MPER, and 4E10 the N-terminus. MPER binding by 2F5 is weakly affected by the TM, whereas MPER binding by 4E10 is stronger in the presence of the HIV TM.

  3. DNA Immunization Results:MPER-PDGFR-TM Targets Abs against the MPER; MPER-HIV-TM Targets the Cytoplasmic Domain

More Related